Global Oligonucleotide Therapeutics Competitive Landscape Professional Research Report 2025
Description
Global Oligonucleotide Therapeutics Competitive Landscape Professional Research Report 2025
Research Summary
Oligonucleotide therapeutics are a class of therapeutic agents that utilize short DNA or RNA molecules, typically consisting of 20-50 nucleotides, to modulate gene expression or target specific disease-causing molecules in the body. These therapeutics can be designed to selectively bind to messenger RNA (mRNA), microRNA (miRNA), or other nucleic acid targets, interfering with their function or promoting specific biological processes. Oligonucleotide therapeutics can act by various mechanisms, including downregulating gene expression through mRNA degradation or blocking translation, correcting abnormal splicing of mRNA, or selectively inhibiting specific proteins or enzymes involved in disease processes. This versatile class of therapeutics has shown promise in treating a wide range of diseases, including genetic disorders, viral infections, neurological disorders, and cancer. Oligonucleotide therapeutics are typically delivered to target tissues or cells through various delivery systems, such as lipid nanoparticles or conjugates. Their development is an active area of research and clinical investigation, with several oligonucleotide-based drugs already approved for clinical use and many more in development.
According to DIResearch's in-depth investigation and research, the global Oligonucleotide Therapeutics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Oligonucleotide Therapeutics include Biogen, Sarepta Therapeutics, Bausch & Lomb, Jazz Pharmaceuticals, Alnylam Pharmaceuticals, Akcea Therapeutics, Dynavax Technologies, Kastle therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oligonucleotide Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oligonucleotide Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oligonucleotide Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oligonucleotide Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Oligonucleotide Therapeutics Include:
Biogen
Sarepta Therapeutics
Bausch & Lomb
Jazz Pharmaceuticals
Alnylam Pharmaceuticals
Akcea Therapeutics
Dynavax Technologies
Kastle therapeutics
Oligonucleotide Therapeutics Product Segment Include:
Antisense Oligonucleotide
Aptamer
Others
Oligonucleotide Therapeutics Product Application Include:
Neuromuscular Diseases
ATTR
Hepatic VOD
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Oligonucleotide Therapeutics Industry PESTEL Analysis
Chapter 3: Global Oligonucleotide Therapeutics Industry Porter’s Five Forces Analysis
Chapter 4: Global Oligonucleotide Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Oligonucleotide Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Oligonucleotide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Oligonucleotide Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Oligonucleotide Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oligonucleotide Therapeutics Product by Type
- 1.2.1 Antisense Oligonucleotide
- 1.2.2 Aptamer
- 1.2.3 Others
- 1.3 Oligonucleotide Therapeutics Product by Application
- 1.3.1 Neuromuscular Diseases
- 1.3.2 ATTR
- 1.3.3 Hepatic VOD
- 1.3.4 Others
- 1.4 Global Oligonucleotide Therapeutics Market Size Analysis (2020-2032)
- 1.5 Oligonucleotide Therapeutics Market Development Status and Trends
- 1.5.1 Oligonucleotide Therapeutics Industry Development Status Analysis
- 1.5.2 Oligonucleotide Therapeutics Industry Development Trends Analysis
- 2 Oligonucleotide Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oligonucleotide Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oligonucleotide Therapeutics Market Analysis by Regions
- 4.1 Oligonucleotide Therapeutics Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Oligonucleotide Therapeutics Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Oligonucleotide Therapeutics Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Oligonucleotide Therapeutics Revenue Forecast by Region (2026-2032)
- 5 Global Oligonucleotide Therapeutics Market Size by Type and Application
- 5.1 Global Oligonucleotide Therapeutics Market Size by Type (2020-2032)
- 5.2 Global Oligonucleotide Therapeutics Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Oligonucleotide Therapeutics Market Size by Type
- 6.4 North America Oligonucleotide Therapeutics Market Size by Application
- 6.5 North America Oligonucleotide Therapeutics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Oligonucleotide Therapeutics Market Size by Type
- 7.4 Europe Oligonucleotide Therapeutics Market Size by Application
- 7.5 Europe Oligonucleotide Therapeutics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Oligonucleotide Therapeutics Market Size by Type
- 8.4 China Oligonucleotide Therapeutics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Oligonucleotide Therapeutics Market Size by Type
- 9.4 APAC (excl. China) Oligonucleotide Therapeutics Market Size by Application
- 9.5 APAC (excl. China) Oligonucleotide Therapeutics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Oligonucleotide Therapeutics Market Size by Type
- 10.4 Latin America Oligonucleotide Therapeutics Market Size by Application
- 10.5 Latin America Oligonucleotide Therapeutics Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Oligonucleotide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Oligonucleotide Therapeutics Market Size by Type
- 11.4 Middle East & Africa Oligonucleotide Therapeutics Market Size by Application
- 11.5 Middle East & Africa Oligonucleotide Therapeutics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Oligonucleotide Therapeutics Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Oligonucleotide Therapeutics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Oligonucleotide Therapeutics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Biogen
- 13.1.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Biogen Oligonucleotide Therapeutics Product Portfolio
- 13.1.3 Biogen Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Sarepta Therapeutics
- 13.2.1 Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Sarepta Therapeutics Oligonucleotide Therapeutics Product Portfolio
- 13.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Bausch & Lomb
- 13.3.1 Bausch & Lomb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Bausch & Lomb Oligonucleotide Therapeutics Product Portfolio
- 13.3.3 Bausch & Lomb Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Jazz Pharmaceuticals
- 13.4.1 Jazz Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Jazz Pharmaceuticals Oligonucleotide Therapeutics Product Portfolio
- 13.4.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Alnylam Pharmaceuticals
- 13.5.1 Alnylam Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Product Portfolio
- 13.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Akcea Therapeutics
- 13.6.1 Akcea Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Akcea Therapeutics Oligonucleotide Therapeutics Product Portfolio
- 13.6.3 Akcea Therapeutics Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Dynavax Technologies
- 13.7.1 Dynavax Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Dynavax Technologies Oligonucleotide Therapeutics Product Portfolio
- 13.7.3 Dynavax Technologies Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Kastle therapeutics
- 13.8.1 Kastle therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Kastle therapeutics Oligonucleotide Therapeutics Product Portfolio
- 13.8.3 Kastle therapeutics Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Oligonucleotide Therapeutics Industry Chain Analysis
- 14.2 Oligonucleotide Therapeutics Industry Raw Material and Suppliers Analysis
- 14.2.1 Oligonucleotide Therapeutics Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Oligonucleotide Therapeutics Typical Downstream Customers
- 14.4 Oligonucleotide Therapeutics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
